The development of insulin resistance is accompanied by an increased insulin secretion, which initially seems to enable normal glucose tolerance to be maintained (Bergman et al. 2002), yet is insufficient to compensate for the decrease in insulin sensitivity after 18 weeks of HFD, as indicated by the hyperinsulinemia yet significant glucose intolerance. The gene discussed is INS; the disease is Hyperinsulinemia.